Biotech · Private company · Ann Arbor, MI, US

Genetobe Inc.

Track this companyFree. Adds Genetobe Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards3

Developing novel Type 1 CRISPR tools for gene editing therapyFiscal year 2024 · $293.3KNIH RePORTER 1R41GM153041-01 · fetched Nov 12, 2026
Novel Selective SGLT-1 Inhibitors for Adjunctive Therapy for Cystic Fibrosis Associated Metabolic DiseasesFiscal year 2024 · $306.8KNIH RePORTER 1R42DK141338-01 · fetched Nov 12, 2026
A Precision Medicine for Alcohol-Associated Liver DiseaseFiscal year 2024 · $982.7KNIH RePORTER 5UT2AA031151-02 · fetched Nov 12, 2026